Effect of the second and third COVID-19 pandemic waves on routine outpatient malaria indicators and case management practices in Uganda: an interrupted time series analysis.
Uganda
/ epidemiology
COVID-19
/ epidemiology
Humans
Malaria
/ drug therapy
Interrupted Time Series Analysis
Case Management
/ statistics & numerical data
Adult
Female
Male
SARS-CoV-2
Outpatients
/ statistics & numerical data
Artemether, Lumefantrine Drug Combination
/ therapeutic use
Antimalarials
/ therapeutic use
Adolescent
Middle Aged
Child
Young Adult
Ambulatory Care
/ statistics & numerical data
Child, Preschool
COVID-19 pandemic
COVID19-wave
Interrupted time series analysis
Malaria
Malaria case management
Outpatient Department
Routine outpatient malaria indicators
Uganda
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
29 Oct 2024
29 Oct 2024
Historique:
received:
05
09
2024
accepted:
21
10
2024
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
epublish
Résumé
Reports on the impact of COVID-19 pandemic on the quality of malaria care and burden in sub Saharan Africa have provided a mixed picture to date. The impact of the 2nd (Delta) and 3rd (Omicron) COVID-19 waves on outpatient malaria indicators and case management practices was assessed at three public health facilities with varying malaria transmission intensities in Uganda. Individual level data from all patients presenting to the out-patient departments (OPD) of the three facilities (Kasambya, Walukuba and Lumino) between January 2019 and February 2022 were included in the analysis. Outcomes of interest included total number of outpatient (OPD) visits, proportion of patients suspected to have malaria, proportion of suspected malaria cases tested with a malaria diagnostic test, test positivity rates (TPR) and proportion of malaria cases prescribed artemether-lumefantrine (AL). Using the pre-COVID-19 trends between January 2019 and February 2020, interrupted time series analysis was used to predict the expected trends for these study outcomes during the 2nd wave (May 2021-August 2021) and 3rd wave (November 2021-February 2022). The observed trends of the study outcomes were compared with the expected trends. There were no significant differences between the observed versus expected overall outpatient visits in the 2nd wave, however, a significant decline in OPD attendance was observed during the 3rd wave (15,101 vs 31,154; incidence rate ratio (IRR) = 0.48 [0.41-0.56]). No significant differences in the overall observed versus expected proportions of suspected malaria cases and test positivity rates in both COVID waves. However, a significant decrease in the overall proportion of suspected malaria cases tested with a malaria diagnostic test was observed during the 3rd wave (99.86% vs 99.99%; relative percent ratio [RPR] = 0.99 [0.99-0.99]). Finally, a significant decline in the overall proportion of malaria cases prescribed AL was observed during the 2nd wave (94.99% vs 99.85%; RPR = 0.95 [0.92-0.98]) but not the 3rd wave. Significant declines in OPD attendance and suspected malaria cases tested with malaria diagnostic test were observed during the 3rd COVID-19 wave, while AL prescription significantly reduced during the 2nd COVID-19 wave. These findings add to the body of knowledge highlighting the adverse impact of COVID-19 pandemic on the malaria which could explain the increase in the malaria burden observed during this period.
Sections du résumé
BACKGROUND
BACKGROUND
Reports on the impact of COVID-19 pandemic on the quality of malaria care and burden in sub Saharan Africa have provided a mixed picture to date. The impact of the 2nd (Delta) and 3rd (Omicron) COVID-19 waves on outpatient malaria indicators and case management practices was assessed at three public health facilities with varying malaria transmission intensities in Uganda.
METHODS
METHODS
Individual level data from all patients presenting to the out-patient departments (OPD) of the three facilities (Kasambya, Walukuba and Lumino) between January 2019 and February 2022 were included in the analysis. Outcomes of interest included total number of outpatient (OPD) visits, proportion of patients suspected to have malaria, proportion of suspected malaria cases tested with a malaria diagnostic test, test positivity rates (TPR) and proportion of malaria cases prescribed artemether-lumefantrine (AL). Using the pre-COVID-19 trends between January 2019 and February 2020, interrupted time series analysis was used to predict the expected trends for these study outcomes during the 2nd wave (May 2021-August 2021) and 3rd wave (November 2021-February 2022). The observed trends of the study outcomes were compared with the expected trends.
RESULTS
RESULTS
There were no significant differences between the observed versus expected overall outpatient visits in the 2nd wave, however, a significant decline in OPD attendance was observed during the 3rd wave (15,101 vs 31,154; incidence rate ratio (IRR) = 0.48 [0.41-0.56]). No significant differences in the overall observed versus expected proportions of suspected malaria cases and test positivity rates in both COVID waves. However, a significant decrease in the overall proportion of suspected malaria cases tested with a malaria diagnostic test was observed during the 3rd wave (99.86% vs 99.99%; relative percent ratio [RPR] = 0.99 [0.99-0.99]). Finally, a significant decline in the overall proportion of malaria cases prescribed AL was observed during the 2nd wave (94.99% vs 99.85%; RPR = 0.95 [0.92-0.98]) but not the 3rd wave.
CONCLUSION
CONCLUSIONS
Significant declines in OPD attendance and suspected malaria cases tested with malaria diagnostic test were observed during the 3rd COVID-19 wave, while AL prescription significantly reduced during the 2nd COVID-19 wave. These findings add to the body of knowledge highlighting the adverse impact of COVID-19 pandemic on the malaria which could explain the increase in the malaria burden observed during this period.
Identifiants
pubmed: 39472901
doi: 10.1186/s12936-024-05153-0
pii: 10.1186/s12936-024-05153-0
doi:
Substances chimiques
Artemether, Lumefantrine Drug Combination
0
Antimalarials
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323Informations de copyright
© 2024. The Author(s).
Références
WHO. World malaria report 2023. Geneva: World Health Organization; 2023.
WHO. Coronavirus disease (COVID-19). Geneva, World Health Organization, 2024 [Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1 .
Alabdulmonem W, Shariq A, Rasheed Z. COVID-19: A global public health disaster. Int J Health Sci. 2020;14:7.
Jain N, Choudhury A, Sharma J, Kumar V, De D, Tiwari R. A review of novel coronavirus infection (Coronavirus Disease-19). Glob J Transfusion Med. 2020;5:22–6.
doi: 10.4103/GJTM.GJTM_24_20
MoH. Annual Health Sector Performance Report Financial year 2022/23. Uganda, Kampala, 2023.
MoH. Uganda Malaria Indicator Survey 2018–19. Uganda, Kampala, 2020.
MoH. Uganda Malaria Indicator Survey 2009. Uganda, Kampala, 2010.
Epstein A, Maiteki-Sebuguzi C, Namuganga JF, Nankabirwa JI, Gonahasa S, Opigo J, et al. Resurgence of malaria in Uganda despite sustained indoor residual spraying and repeated long lasting insecticidal net distributions. PLoS Glob Public Health. 2022;2: e0000676.
doi: 10.1371/journal.pgph.0000676
pmcid: 10022262
pubmed: 36962736
Nankabirwa JI, Bousema T, Blanken SL, Rek J, Arinaitwe E, Greenhouse B, et al. Measures of malaria transmission, infection, and disease in an area bordering two districts with and without sustained indoor residual spraying of insecticide in Uganda. PLoS ONE. 2022;17: e0279464.
doi: 10.1371/journal.pone.0279464
pmcid: 9803187
pubmed: 36584122
Weiss DJ, Bertozzi-Villa A, Rumisha SF, Amratia P, Arambepola R, Battle KE, et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. Lancet Infect Dis. 2021;21:59–69.
doi: 10.1016/S1473-3099(20)30700-3
pmcid: 7505634
pubmed: 32971006
Caglar B, Karaali R, Balkan II, Mete B, Aygun G. COVID-19 and Plasmodium ovale malaria: a rare case of co-infection. Korean J Parasitol. 2021;59:399–402.
doi: 10.3347/kjp.2021.59.4.399
pmcid: 8413863
pubmed: 34470091
Hussein MIH, Albashir AAD, Elawad OAMA, Homeida A. Malaria and COVID-19: unmasking their ties. Malar J. 2020;19:457.
doi: 10.1186/s12936-020-03541-w
pmcid: 7755982
pubmed: 33357220
Kitara DL, Ikoona EN. COVID-19 pandemic, Uganda’s story. Pan Afr Med J. 2020;35(Suppl 2):51.
pmcid: 7875747
pubmed: 33623576
Mahmud M, Riley E. Household response to an extreme shock: Evidence on the immediate impact of the Covid-19 lockdown on economic outcomes and well-being in rural Uganda. World Dev. 2021;140: 105318.
doi: 10.1016/j.worlddev.2020.105318
pubmed: 34548741
Kagirita A, Muruta A. National Guidelines for quarantine in the context of COVID-19. MoH Knowledge Portal, Uganda, Kampala. 2020.
Namuganga JF, Briggs J, Roh ME, Okiring J, Kisambira Y, Sserwanga A, et al. Impact of COVID-19 on routine malaria indicators in rural Uganda: an interrupted time series analysis. Malar J. 2021;20:475.
doi: 10.1186/s12936-021-04018-0
pmcid: 8685800
pubmed: 34930317
Bongomin F, Fleischer B, Olum R, Natukunda B, Kiguli S, Byakika-Kibwika P, et al. High mortality during the second wave of the coronavirus disease 2019 (COVID-19) pandemic in Uganda: experience from a national referral COVID-19 treatment unit. Open Forum Infect Dis. 2021;8:1–7.
doi: 10.1093/ofid/ofab530
Okello PE, Van Bortel W, Byaruhanga AM, Correwyn A, Roelants P, Talisuna A, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Infect Dis. 2006;75:219–25.
Mawejje HD, Asiimwe JR, Kyagamba P, Kamya MR, Rosenthal PJ, Lines J, et al. Impact of different mosquito collection methods on indicators of Anopheles malaria vectors in Uganda. Malar J. 2022;21:388.
doi: 10.1186/s12936-022-04413-1
pmcid: 9761930
pubmed: 36536428
Linden A. A comprehensive set of postestimation measures to enrich interrupted time-series analysis. Stata J. 2017;17:73–88.
doi: 10.1177/1536867X1701700105
Heuschen A-K, Abdul-Mumin A, Abubakari A, Agbozo F, Lu G, Jahn A, et al. Effects of the COVID-19 pandemic on general health and malaria control in Ghana: a qualitative study with mothers and health care professionals. Malar J. 2023;22:78.
doi: 10.1186/s12936-023-04513-6
pmcid: 9986038
pubmed: 36872343
Duguay C, Accrombessi M, N’Tcha LK, Akinro BA, Dangbenon E, Assongba L, et al. Community-level impacts of the coronavirus pandemic on malaria prevention and health-seeking behaviours in rural Benin: a mixed methods study. PLoS Glob Public Health. 2023;3: e0001881.
doi: 10.1371/journal.pgph.0001881
pmcid: 10198503
pubmed: 37205645
Heuschen A-K, Abdul-Mumin A, Adokiya M, Lu G, Jahn A, Razum O, et al. Impact of the COVID-19 pandemic on malaria cases in health facilities in northern Ghana: a retrospective analysis of routine surveillance data. Malar J. 2022;21:149.
doi: 10.1186/s12936-022-04154-1
pmcid: 9107588
pubmed: 35570272
Ilesanmi OS, Afolabi AA, Iyiola OP. Effect of the COVID-19 pandemic on malaria intervention coverage in Nigeria: analysis of the premise malaria COVID-19 health services disruption survey 2020. Population Med. 2021;3:1–10.
doi: 10.18332/popmed/141979
Hakizimana D, Ntizimira C, Mbituyumuremyi A, Hakizimana E, Mahmoud H, Birindabagabo P, et al. The impact of Covid-19 on malaria services in three high endemic districts in Rwanda: a mixed-method study. Malar J. 2022;21:48.
doi: 10.1186/s12936-022-04071-3
pmcid: 8845295
pubmed: 35164781
Guerra CA, Tresor Donfack O, Motobe Vaz L, Mba Nlang JA, Nze Nchama LO, Mba Eyono JN, et al. Malaria vector control in sub-Saharan Africa in the time of COVID-19: no room for complacency. BMJ Glob Health. 2020;5: e003880.
doi: 10.1136/bmjgh-2020-003880
pubmed: 32938611
Miller JS, Mulogo EM, Wesuta AC, Mumbere N, Mbaju J, Matte M, et al. Long-term quality of integrated community case management care for children in Bugoye Subcounty, Uganda: a retrospective observational study. BMJ Open. 2022;12: e051015.
doi: 10.1136/bmjopen-2021-051015
pmcid: 9036460
pubmed: 35459661
NMCP Ministry of Health. Third national mass campaign for universal access to long-lasting insecticide-treated mosquito nets (llins) for malaria prevention in Uganda. Uganda, Kampala, 2021.
Mungmunpuntipantip R, Wiwanitkit V. COVID lockdown and malaria incidence: A note from the tropical endemic area. APIK J Int Med. 2023;11:137–8.
doi: 10.4103/ajim.ajim_123_22
Ministry of Health. The malaria weekly bulletin for Epi week 31 (1st August–7th August 2022); periodical report. Uganda, Kampala, 2022.
Gavi S, Tapera O, Mberikunashe J, Kanyangarara M. Malaria incidence and mortality in Zimbabwe during the COVID-19 pandemic: analysis of routine surveillance data. Malar J. 2021;20:233.
doi: 10.1186/s12936-021-03770-7
pmcid: 8142064
pubmed: 34030711
Bylicka-Szczepanowska E, Korzeniewski K. Asymptomatic malaria infections in the time of COVID-19 pandemic: experience from the Central African Republic. Int J Environ Res Public Health. 2022;19:3544.
doi: 10.3390/ijerph19063544
pmcid: 8951439
pubmed: 35329229
Manga IA, Seye C, Dramé A, Fall CB, Lélo S, Minlekib CP, et al. Impact of COVID-19 on biological diagnosis of malaria: case of the Thierno Mouhamadoul Mansour Barro Hospital in Mbour, Senegal. Adv Infect Dis. 2023;13:31–40.
Afai G, Banze AR, Candrinho B, Baltazar CS, Rossetto EV. Challenges for malaria surveillance during the COVID-19 emergency response in Nampula, Mozambique, January–May 2020. Pan Afr Med J. 2021;38:254.
doi: 10.11604/pamj.2021.38.254.27481
pmcid: 8164433
pubmed: 34104302
Aborode AT, David KB, Uwishema O, Nathaniel AL, Imisioluwa JO, Onigbinde SB, et al. Fighting COVID-19 at the expense of malaria in Africa: the consequences and policy options. Am J Trop Med Hyg. 2021;104:26–9.
doi: 10.4269/ajtmh.20-1181
pubmed: 33205743
WHO. A double challenge: Tackling COVID-19 and malaria in Uganda. Geneva: World Health Organization; 2020.
Dzianach PA, Rumisha SF, Lubinda J, Saddler A, van den Berg M, Gelaw YA, et al. Evaluating COVID-19-related disruptions to effective malaria case management in 2020–2021 and its potential effects on malaria burden in sub-Saharan Africa. Trop Med Infect Dis. 2023;8:216.
doi: 10.3390/tropicalmed8040216
pmcid: 10143572
pubmed: 37104342